Work

527. GM-2040 is a Novel Putative Non-Hallucinogenic 5-HT2A Agonist With Attenuated Head Twitch and Retained Antidepressant Activity

Year: 2023

Type: article

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2023.02.767

Authors: Adam Klein, Eric Austin, Dino Dvorak, Gerard Marek, Jonathan Sporn, Laszlo Kiss, Zoe Hughes, Andrew Kruegel

Institution: Gilgamesh Pharma (United States)

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4362734124

FWCI:

Cites:

Cited by:

Related to: 10